ELISA Immunoassay Reagents - Respiratory Disease Detection Series

Molecular diagnostic reagents for identifying RNA from respiratory pathogens including influenza, COVID-19, and other airborne viruses. Products enable rapid and accurate diagnosis for acute respiratory infection management.

Chromatographic reagent kit for respiratory infection and viral marker detection. Optimized for rapid point-of-care diagnostic applications.

A series of RNA-based diagnostic tests for respiratory tract infections. These tests support diagnosis and treatment monitoring of respiratory pathogens including tuberculosis and influenza.

Clinical reagents for RNA-based detection of enteric viruses causing gastrointestinal infections. These products provide molecular identification of viral pathogens for outbreak investigation and patient management.

A series of diagnostic assays designed for detection of infectious disease markers and pathogens. The assays include testing for various viral, bacterial, and parasitic infections relevant to clinical diagnostics.

A comprehensive series of diagnostic tests for the detection of various infectious diseases. These products enable rapid identification of pathogenic infections.

Specialized diagnostic products and assays for respiratory infectious disease detection, providing healthcare professionals with fast and reliable results.

Ready-to-use ELISA reagents for serological diagnosis of infectious diseases in humans. These tests detect bacteria, viruses, parasites, and fungi across a wide range of infectious disease applications.

Diagnostic test specifically designed for detecting respiratory tract infections. Supports rapid identification of viral, bacterial, or atypical respiratory pathogens.

Respiratory disease rapid test kits that detect a wide range of pathogens including influenza A/B, RSV, SARS-CoV-2 and more. Using Colloidal Gold and Fluorescence Immunoassay technologies with multiplex respiratory panel formats available, they support early intervention and point-of-care respiratory testing.

In vitro diagnostic reagents for detecting respiratory tract pathogens. The company manufactures these products using colloidal gold and fluorescence immunoassay technology platforms. Products are available with multiple regulatory certifications including CE marking and NMPA registration.

In vitro diagnostic tests for detection and identification of respiratory pathogens and biomarkers. Applicable for viral, bacterial, and inflammatory respiratory disease diagnosis.